Assessment of Generic Drug Policy Implementation by Measuring Persistence With Antihypertensive Drug Therapies After Patent Expiry

Value in Health - United Kingdom
doi 10.1016/j.jval.2013.08.1348
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Impact of Generic Drug Policy on Drug Pricing

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Antihypertensive Drug Therapy

Annals of Translational Medicine
Medicine
2018English

AIDS Drug Patent

Nature
Multidisciplinary
1988English

Individualization of Antihypertensive Drug Treatment

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2013English

Beyond Patent Expiry: Development of a Model for Pricing Generic Drugs in South Africa

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Characteristics of Recent Generic Drug Approvals by the US Food and Drug Administration

JAMA network open
Medicine
2019English

Comparison of Economic Loss Between Generic Drug and Patent Drug in Stock-Out and Stagnant Condition at Surabaya Islamic Hospital, Indonesia

Journal of Public Health in Africa
EnvironmentalPublic HealthOccupational Health
2019English

Rationalizing the Drug Patent System

Health Affairs
MedicineHealth Policy
2001English

Factors Related to Non-Compliance With Antihypertensive Drug Therapy

Journal of Human Hypertension
Internal Medicine
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy